Anti-TMPRSS6 Monoclonal Antibodies and Therapeutic Uses

Fri, 10 Apr 2026 02:46:17 +0000
Intellectual Property

USPTO published patent application US20260098084A1 disclosing fully human anti-TMPRSS6 monoclonal antibodies for treating diseases associated with TMPRSS6. Inventors include Harvey Chin, Sarah J. Hatsell, Heinrich Emil Lob, Andrew J. Murphy, William Olson, Kei Saotome, and Bojie Zhang, with application number 19323318 filed September 9, 2025.